Clinical Trials Directory

Trials / Completed

CompletedNCT04369443

Application of Large Volume Acute Normovolemic Hemodilution in Cardiac Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The application of acute Normovolemic Hemodilution in cardiac surgery can effectively reduce perioperative blood transfusion, reduce postoperative complications and mortality, and is a low-cost, operable and effective blood protection measure.For the application of Acute Normovolemic Hemodilution in heart surgery, we still face an urgent problem: to what extent can Acute Normovolemic Hemodilution achieve better "blood saving effect", that is, whether a large number of Acute Normovolemic Hemodilution can reduce perioperative blood transfusion to a greater extent

Conditions

Interventions

TypeNameDescription
PROCEDURELarge volume Acute Normovolemic HemodilutionFollowing induction of anesthesia, the volume of blood to be removed during Acute Normovolemic Hemodilution was calculated using an established formula:V=Weight(Kg)×12-15(mL/Kg);Blood to be removed was capped at: Vmax=EVB×(Hi-Hf)/Hav(EBV= estimated blood volume (male:70mL/Kg,female:65mL/Kg);Hi= initial hemoglobin ;Hf=target Hb( 10g/dL );Hav= the average of the initial and minimal allowable hemoglobin).Ensure the volume of removed blood does not exceed the upper limit and Hb ≥10g/dL after blood removed.

Timeline

Start date
2020-05-01
Primary completion
2021-01-30
Completion
2021-01-30
First posted
2020-04-30
Last updated
2023-02-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04369443. Inclusion in this directory is not an endorsement.

Application of Large Volume Acute Normovolemic Hemodilution in Cardiac Surgery (NCT04369443) · Clinical Trials Directory